WCM Investment Management
CBPO

WCM Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

WCM Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-46,252
Closed -$4.27M – 98
2017
Q3 		$4.27M Buy
+46,252
New +$4.44M 0.05% 46
2017
Q2 		– Sell
-65,715
Closed -$6.58M – 92
2017
Q1 		$6.58M Sell
65,715
-4,473
-6% -$478K 0.07% 61
2016
Q4 		$7.55M Sell
70,188
-2,982
-4% -$349K 0.09% 59
2016
Q3 		$9.11M Buy
73,170
+3,194
+5% +$377K 0.1% 57
2016
Q2 		$7.44M Buy
69,976
+8,378
+14% +$973K 0.12% 62
2016
Q1 		$7.05M Buy
61,598
+845
+1% +$99.1K 0.11% 70
2015
Q4 		$8.65M Buy
60,753
+11,282
+23% +$1.3M 0.18% 64
2015
Q3 		$4.44M Sell
49,471
-7,688
-13% -$812K 0.11% 84
2015
Q2 		$6.58M Buy
+57,159
New +$6.01M 0.15% 85

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

WCM Investment Management's CBPO Position: Q4 2017 in Review

WCM Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2017, closing a stake of 46,252 shares — an estimated $4.27M sold.

WCM Investment Management first reported a position in CBPO in Q2 2015 and held it in 9 quarters. The position peaked at $9.11M in Q3 2016. 93 funds tracked by Wall St. Rank hold CBPO as of Q4 2017.

  • WCM Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2017 after selling out during the quarter.
  • WCM Investment Management sold 46,252 China Biologic Products Holdings, Inc. shares in Q4 2017, an estimated $4.27M.
  • WCM Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 9 quarters.
  • WCM Investment Management's China Biologic Products Holdings, Inc. position peaked at $9.11M in Q3 2016.
  • 93 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2017.

Based on WCM Investment Management's 13F filing for Q4 2017, filed 6 Feb 2018.